129 related articles for article (PubMed ID: 8577372)
21. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
22. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
[TBL] [Abstract][Full Text] [Related]
23. CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification.
Branchereau P; Böhme GA; Champagnat J; Morin-Surun MP; Durieux C; Blanchard JC; Roques BP; Denavit-Saubié M
J Pharmacol Exp Ther; 1992 Mar; 260(3):1433-40. PubMed ID: 1545402
[TBL] [Abstract][Full Text] [Related]
24. CholecystokininB receptor antagonist increases food intake in rats.
Dorré D; Smith GP
Physiol Behav; 1998 Aug; 65(1):11-4. PubMed ID: 9811359
[TBL] [Abstract][Full Text] [Related]
25. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.
Swanson LW; Simmons DM
J Comp Neurol; 1989 Jul; 285(4):413-35. PubMed ID: 2569487
[TBL] [Abstract][Full Text] [Related]
26. Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
Frankland PW; Josselyn SA; Bradwejn J; Vaccarino FJ; Yeomans JS
J Neurosci; 1997 Mar; 17(5):1838-47. PubMed ID: 9030642
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat.
Gaw AJ; Hills DM; Spraggs CF
Br J Pharmacol; 1995 Jun; 115(4):660-4. PubMed ID: 7582487
[TBL] [Abstract][Full Text] [Related]
28. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin.
Wigger A; Sánchez MM; Mathys KC; Ebner K; Frank E; Liu D; Kresse A; Neumann ID; Holsboer F; Plotsky PM; Landgraf R
Neuropsychopharmacology; 2004 Jan; 29(1):1-14. PubMed ID: 12942143
[TBL] [Abstract][Full Text] [Related]
29. Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport.
Rao RK; Levenson S; Fang SN; Hruby VJ; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1994 Feb; 268(2):1003-9. PubMed ID: 8113956
[TBL] [Abstract][Full Text] [Related]
30. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Corp ES; McQuade J; Moran TH; Smith GP
Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
[TBL] [Abstract][Full Text] [Related]
31. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression.
Sipols AJ; Baskin DG; Schwartz MW
Diabetes; 1995 Feb; 44(2):147-51. PubMed ID: 7859932
[TBL] [Abstract][Full Text] [Related]
32. Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin-releasing factor mRNA stimulation in the rat.
Lightman SL; Young WS
J Physiol; 1987 Dec; 394():23-39. PubMed ID: 2895179
[TBL] [Abstract][Full Text] [Related]
33. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
[TBL] [Abstract][Full Text] [Related]
34. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
Beinborn M; Chen C; DeMeo L; McBride EW; Kopin AS
Yale J Biol Med; 1998; 71(3-4):337-46. PubMed ID: 10461364
[TBL] [Abstract][Full Text] [Related]
35. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
Singh L; Field MJ; Vass CA; Hughes J; Woodruff GN
Br J Pharmacol; 1992 Jan; 105(1):8-10. PubMed ID: 1350747
[TBL] [Abstract][Full Text] [Related]
36. Effect of ionizing radiation on the release of cholecystokinin in the hypothalamus of the rat.
Kandasamy SB
Radiat Res; 1998 Sep; 150(3):298-303. PubMed ID: 9728659
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide synthase increases in hypothalamic magnocellular neurons after salt loading in the rat. An immunohistochemical and in situ hybridization study.
Villar MJ; Ceccatelli S; Rönnqvist M; Hökfelt T
Brain Res; 1994 May; 644(2):273-81. PubMed ID: 7519526
[TBL] [Abstract][Full Text] [Related]
38. A cholecystokinin-B receptor antagonist potentiates GABAergic and glycinergic inhibition in the nucleus of the solitary tract of the rat.
McLean HA; Champagnat J; Denavit-Saubie M
Eur J Neurosci; 1996 Jun; 8(6):1078-84. PubMed ID: 8752577
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
Lu L; Zhang B; Liu Z; Zhang Z
Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
